What is the main business of Syntplant?

The main business activity of Syntplant focuses on manufacture of medical and dental instruments and supplies.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on March 21, 2012.

Where is the headquarters located?

The headquarters is located at: Rubież 46, 61-612 Poznań.

Who is on the management board?

The management board consists of: Marcin Andrzej Wątrobiński (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 117,650 (approx. $31,780).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2020 to December 31, 2020.

What was the revenue?

In 2020, the company's revenue reached $105,188.

Is the company profitable?

Yes, the company recorded a net profit of $27,277 in 2020.

What is the main operating cost?

The largest operating cost category falls under employee remuneration. This category amounted to $35,045 in 2020, representing 45% of all operating expenses.

Syntplantsp. z o.o.

Manufacture of medical and dental instruments and supplies

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2012-03-21

Share capital

117,650.00 PLN

Registered address

Rubież 46/Budynek c4, 61-612 Poznań, Poland

Electronic delivery address

AE:PL-68147-54848-TDTVF-14

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2021 – the filing deadline has passed. 3 of 3 financial statements were filed late (the longest delay 268 days for 2018).

2021not filed
202008/01/2022
201911/12/2020
201808/04/2020

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2020.

Results vs industry

Revenue

This companyUSD 105.19kMedianUSD 287.80kAverageUSD 4.91m

Net profit

This companyUSD 27.28kMedianUSD 12.59kAverageUSD 208.04k

Operating costs

This companyUSD 77.81kMedianUSD 272.78kAverageUSD 4.49m

Assets

This companyUSD 236.44kMedianUSD 224.38kAverageUSD 5.76m

Industry

Trademarks

Syntplant currently holds no active trademarks with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2013.

Mark	Number	Classes	Status	Protected until
cyberbone	Z.522644	10	Proceedings discontinued	–
Syntplant	Z.412212	42	Expired	–

Mark	Protected until
cyberbone	–
Syntplant	–

Authorized Representatives

Marcin Andrzej Wątrobiński – President of the Management Board

Manner of representation

Each member of the management board is authorized to represent the company.

Ownership

Owner	Shares	Share value	Stake
Krzysztof Piotr Horałaage 65	353	$4,767.69	15.0021%
Marcin Andrzej Wątrobińskiage 51	1,971	$26,620.75	83.7654%
Others	29	$391.68	1.2325%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2019-05-01.

Bank Millennium
19 1160 2202 0000 0006 3464 4884

Debt

2 active proceedings recorded in KRZ.

Registration date	Proceeding type	Status
Jul 31, 2024	Petition to declare entrepreneur bankruptcy	In progress
Jul 23, 2024	Petition to open arrangement proceedings	Closed

Public aid

6 public aid cases recorded, with a total value of $1,537,857.

Grant date	Purpose	Gross amount	Granting body
Nov 30, 2022	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$1,653$1,653	Prezes Zakładu Ubezpieczeń Społecznych
Dec 28, 2020	Aid for research and development projects: industrial research	$356.2K$356,212	Dyrektor Narodowego Centrum Badań i Rozwoju
Dec 28, 2020	Aid for research and development projects: experimental development	$228K$227,996	Dyrektor Narodowego Centrum Badań i Rozwoju

European Funds

Start	Project	EU co-financing	Programme
2020-02-01	Development of customised biodegradable implants for bone reconstruction procedures	$1.8M$1,758,832	Operational Programme Smart Growth

Competitors

Name	Revenue	Website
DCD Labsp. z o.o.	$3,056,950.70	dcd-lab.pl
Markdentsp. z o.o.	$129,752.97	mark-dent.pl
Simonsp. z o.o.	$123,787.79	simonseat.com
Astendsp. z o.o.	$105,928.35	astend.pl
EndolinkS.A.	$84,803.59	endolink.pl
UnitedmedP.S.A.	$79,858.73	united-med.pl
PhilabsS.A.	$64,403.10	phibox.eu
K&J Polskasp. z o.o.	$70,953.51	kjpolska.pl
OsteonovaP.S.A.	–	osteonova.eu
Pinklabsp. z o.o.	–	pinklab.pl

Change history

Date	Event
2020-11-26	Share capital increase (100,000.00 PLN → 117,650.00 PLN)
2020-07-14	Share capital increase (5,000.00 PLN → 100,000.00 PLN)
2019-04-25	Business resumed
2018-08-01	Business suspended
2014-03-10	Address change (Partyzantów 62, 29-100, Włoszczowa → Rubież 46/Budynek C4, 61-612, Poznań)

FAQ

Last updated: 2026-04-22